tiprankstipranks
Trending News
More News >
Molecular Partners AG (CH:MOLN)
:MOLN

Compare Molecular Partners AG (MOLN) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Molecular Partners AG
CHF3.41
CHF134.04M
-2.05
-10.03%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF3.40
CHF736.64M
-8.17
210.79%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF16.36
CHF339.62M
-487.07
94.30%
1 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF14.54
$204.05M
-0.98
-3.07%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF24.00
CHF132.65M
4.27
17.95%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:MOLN
Molecular Partners AG
3.32
-0.18
-5.14%
CH:IDIA
Idorsia Ltd
3.40
2.22
188.14%
CH:NWRN
Newron Pharmaceuticals SpA
16.36
7.76
90.23%
CH:SANN
Santhera Pharmaceuticals Holding
14.54
-0.26
-1.76%
CH:RLF
CH:XLS
Xlife Sciences Ltd.
23.00
3.10
15.58%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts